wunder beta🤧 Why do we get allergies?
Follow an allergy from failed tolerance and allergen-specific IgE to mast-cell activation, tissue symptoms, cross-reactivity, and the immune memory that makes reactions persist yet vary.
What you’ll learn
- Sensitization Reclassifies a Harmless SubstanceExplain allergy as a failure of antigen-specific tolerance involving epithelial context, type 2 signaling, B-cell class switching, and IgE sensitization.An allergen is not necessarily harmful in itself. Body barriers and immune regulators usually support tolerance, but genetic and environmental context can bias a specific response toward type 2 immunity. B cells then produce allergen-specific IgE that arms mast cells and basophils for re-exposure.
- Re-Exposure Triggers Tissue EffectsTrace IgE receptor cross-linking through mast-cell mediator release to tissue-specific immediate and late allergic effects.A matching multivalent allergen clusters IgE-bound receptors and activates sensitized effector cells. Histamine acts quickly alongside proteases, lipids, cytokines, and chemokines. Tissue anatomy turns those mediators into different symptoms, and later recruited inflammation can extend the reaction.
- Allergy Is Specific but VariableDistinguish cross-reactivity, sensitization, and clinical allergy while explaining context-dependent thresholds and persistent allergic memory.IgE can recognize similar epitopes across sources, but molecular binding does not guarantee clinical reaction. Diagnosis requires context beyond a positive test. Dose, route, tissue state, and cofactors shift activation thresholds, while plasma cells and memory responses make sensitization persistent yet biologically changeable.
Questions this course answers
What makes a harmless environmental protein an allergen for one person?
Allergen status reflects a specific learned relationship between a molecule and a sensitized host, shaped by exposure route, tissue context, immune regulation, genes, and environment.
Put an immediate IgE-mediated allergic reaction in causal order.
Prior sensitization arms the cell. Re-exposure clusters receptors, activates the mast cell, and releases mediators whose tissue targets create symptoms.
Why can someone have detectable allergen-specific IgE without having a clinically important allergy?
Antibody binding is one layer of the mechanism. Cross-reactivity, dose, route, tissue state, and effector-cell responsiveness determine whether that recognition becomes a meaningful reaction.
Grounded in trusted sources
- Galli and Tsai, IgE and Mast Cells in Allergic Disease — https://pmc.ncbi.nlm.nih.gov/articles/PMC3597223/
- Allen, Features of B Cell Responses Relevant to Allergic Disease — https://pmc.ncbi.nlm.nih.gov/articles/PMC10054180/
- Noval Rivas and Chatila, Regulatory T Cells in Allergic Diseases — https://pmc.ncbi.nlm.nih.gov/articles/PMC5023156/
- Lu et al., Involvement and Repair of Epithelial Barrier Dysfunction in Allergic Diseases — https://pmc.ncbi.nlm.nih.gov/articles/PMC10867171/
- Sharma and Vitte, A Systematic Review of Allergen Cross-Reactivity: Translating Basic Concepts Into Clinical Relevance — https://pmc.ncbi.nlm.nih.gov/articles/PMC10959674/
- Ansotegui et al., IgE Allergy Diagnostics and Other Relevant Tests in Allergy: A World Allergy Organization Position Paper — https://pmc.ncbi.nlm.nih.gov/articles/PMC7044795/
Every Wunder lesson is built from real, reputable sources — never invented.
Related Science courses
Wunder is a personalized learn-anything platform — tell it any topic and it builds a beautiful, fact-checked course in minutes, with narration, a knowledge check, and a college-style University track.
Browse more Science courses · All topics · Home
© 2026 Wunder Learning LLC · Terms & Privacy